Background illustration for clinical trials search

Paid Clinical Trials Cincinnati

Discover 1,164 paid clinical trials in Cincinnati, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

for
Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer,
Location: Cincinnati OH, Fairfield OH, Orrville OH, Massillon OH,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07222566

Phase3, Recruiting

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

for
Breast Cancer
Location: Cincinnati OH, Chicago IL, Zion IL, St Louis MO,
Sponsor: Greenwich LifeSciences, Inc.

Sex: All

Age: 18 - 70+

Code: NCT05232916

Phase3, Recruiting

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

for
Melanoma
Location: Cincinnati OH, Lexington KY, Columbus OH, Fort Wayne IN,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06246916

Phase3, Recruiting

Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

for
Metastatic Melanoma, Unresectable Melanoma, Melanoma
Location: Cincinnati OH, Columbus OH, Detroit MI, Nashville TN,
Sponsor: Iovance Biotherapeutics, Inc.

Sex: All

Age: 18 - 70

Code: NCT05727904

Phase3, Recruiting

BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)

for
Limited Stage Small Cell Lung Cancer
Location: Cincinnati OH, Lexington KY, Louisville KY,
Sponsor: SCRI Development Innovations, LLC

Sex: All

Age: 18+

Code: NCT06773910

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Cincinnati OH, Louisville KY, Columbus OH, Nashville TN,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT06297226

Phase2, Recruiting

CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER)

for
Lymphoma, Non-Hodgkin, Relapsed Non Hodgkin Lymphoma,
Location: Cincinnati OH, Lexington KY, Louisville KY,
Sponsor: Caribou Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT04637763

Phase1, Recruiting

Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma

for
Multiple Myeloma
Location: Cincinnati OH, Nashville TN, Roanoke VA, Fairfax VA,
Sponsor: SCRI Development Innovations, LLC

Sex: All

Age: 18+

Code: NCT05972135

Phase2, Recruiting

A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer

for
Metastatic HER2-positive Breast Cancer
Location: Cincinnati OH, Nashville TN, Asheville NC, Roanoke VA,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06435429

Phase3, Recruiting

Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors

for
Rare Unresectable or Metastatic BRAF V600E Mutation-positive Solid Tumors,
Location: Cincinnati OH, Nashville TN, Durham NC,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 1 - 70+

Code: NCT05868629

Recruiting

Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Location: Cincinnati OH, Nashville TN, Pittsburgh PA, Durham NC,
Sponsor: Amgen

Sex: Male

Age: 18+

Code: NCT07493512

Phase1, Recruiting

A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer
Location: Cincinnati OH, Nashville TN, Niles IL, Peoria IL,
Sponsor: BioNTech SE

Sex: Male

Age: 18+

Code: NCT07365995

Phase3, Recruiting

Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer

for
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction , or Esophageal Adenocarcinoma,
Location: Cincinnati OH, Fairfield OH, Bloomington IL, Chicago IL,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07392892

Phase2, Phase3, Recruiting

A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

for
Small Cell Lung Cancer
Location: Cincinnati OH, Lexington KY, Canton OH, Chicago IL,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06203210

Phase3, Recruiting

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

for
Ovarian Neoplasms, Fallopian Tube Neoplasms,
Location: Cincinnati OH, Centerville OH, Lexington KY,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07213804

Phase3, Recruiting

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer
Location: Cincinnati OH, Dayton OH, Louisville KY, Columbus OH,
Sponsor: Amgen

Sex: Male

Age: 18+

Code: NCT07213674

Phase3, Recruiting

A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

for
Ovarian Cancer
Location: Cincinnati OH, Louisville KY, Hilliard OH, Columbus OH,
Sponsor: Incyte Corporation

Sex: Female

Age: 18 - 70+

Code: NCT07023627

Phase2, Recruiting

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

for
Leukemia, Myeloid, Acute
Location: Cincinnati OH, Centerville OH, Lexington KY,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06852222

Phase3, Recruiting

A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Cincinnati OH, Louisville KY, Chattanooga TN,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06943872

Phase3, Recruiting

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

for
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic,
Location: Cincinnati OH, Fairfield OH, Louisville KY, Avon OH,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07144280

Phase3, Recruiting